Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIAject vs Regular Human Insulin in Type 2 Diabetes
NCT00542633Phase 3Completed
- Sponsor
- Biodel Inc.
- Start
- Dec 2006
- Primary completion
- Aug 2008
01
Overview
A Phase 3 trial of VIAject in type 2 diabetes mellitus (T2DM), sponsored by Biodel Inc.. Started Dec 2006; status: completed.
02
Drugs
VIAject
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00542633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542633.